# William C. Chapman

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/william-c-chapman/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,202 |
| Field | Organ Transplantation Techniques and Outcomes |
| h-index | 47 |
| i10-index | 118 |
| Last Known Institution | Washington University in St. Louis |
| OpenAlex ID | https://openalex.org/A5103223377 |
| ORCID iD | 0000-0002-0072-3239 |
| Works | 247 |

## Researcher papers

- [Comparison of the transcriptional landscapes between human and mouse tissues](https://scholariq.org/papers/comparison-of-the-transcriptional-landscapes-between-human-and-mouse-tissues/)
- [Everolimus With Reduced Tacrolimus Improves Renal Function in De Novo Liver Transplant Recipients: A Randomized Controlled Trial](https://scholariq.org/papers/everolimus-with-reduced-tacrolimus-improves-renal-function-in-de-novo-liver/)
- [Outcomes of Neoadjuvant Transarterial Chemoembolization to Downstage Hepatocellular Carcinoma Before Liver Transplantation](https://scholariq.org/papers/outcomes-of-neoadjuvant-transarterial-chemoembolization-to-downstage/)
- [Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study](https://scholariq.org/papers/renal-function-at-two-years-in-liver-transplant-patients-receiving-everolimus/)
- [Impact of Pretransplant Bridging Locoregional Therapy for Patients With Hepatocellular Carcinoma Within Milan Criteria Undergoing Liver Transplantation](https://scholariq.org/papers/impact-of-pretransplant-bridging-locoregional-therapy-for-patients-with/)
- [Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma](https://scholariq.org/papers/antibody-mediated-therapy-targeting-cd47-inhibits-tumor-progression-of/)
- [<i>The Role of \[</i> <sup> <i>18</i> </sup> <i>F\]Fluorodeoxyglucose Positron Emission Tomography Imaging in the Evaluation of Hepatocellular Carcinoma</i>](https://scholariq.org/papers/i-the-role-of-i-sup-i-18-i-sup-i-f-fluorodeoxyglucose-positron-emission/)
- [Antibodies to MHC Class I Induce Autoimmunity: Role in the Pathogenesis of Chronic Rejection](https://scholariq.org/papers/antibodies-to-mhc-class-i-induce-autoimmunity-role-in-the-pathogenesis-of/)
- [Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma](https://scholariq.org/papers/ten-year-outcomes-of-liver-transplant-and-downstaging-for-hepatocellular/)
- [Assessment and optimization of liver volume before major hepatic resection: Current guidelines and a narrative review](https://scholariq.org/papers/assessment-and-optimization-of-liver-volume-before-major-hepatic-resection/)
- [Venous Thromboembolism Prophylaxis Practice Patterns, Outcomes, and Risk Stratification After Surgery for IBD: A National Surgical Quality Improvement Program IBD Collaborative Study](https://scholariq.org/papers/venous-thromboembolism-prophylaxis-practice-patterns-outcomes-and-risk/)

## Researcher topics

- [Organ Transplantation Techniques and Outcomes](https://scholariq.org/topics/organ-transplantation-techniques-and-outcomes/)
- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Liver Disease Diagnosis and Treatment](https://scholariq.org/topics/liver-disease-diagnosis-and-treatment/)
- [Liver Disease and Transplantation](https://scholariq.org/topics/liver-disease-and-transplantation/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [Washington University in St. Louis](https://scholariq.org/institutions/washington-university-in-st-louis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.